May 16, 2022 / NTS GMT
Presentation
May 16, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Miwako Harada
Sumitomo Pharma Co., Ltd. - Senior Director of Corporate Communications
* Toru Kimura
Sumitomo Pharma Co., Ltd. - Executive VP & Representative Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Exe. Officer of Cancer, Modality & Drug Research Div., Head of Japan Busi Unit and Director
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
Sumitomo Pharma Co Ltd
(OTCPK:DNPUF)
$
4.3
0 (0%)
Market Cap: 1.52 Bil
Enterprise Value: 3.31 Bil
PE Ratio: 0
PB Ratio: 2.04
GF Score: 64/100 Full Year 2022 Sumitomo Pharma Co Ltd Earnings Presentation Transcript
May 16, 2022 / NTS GMT
Release Date Price:
$9.69
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot